Cao, Xiao
Rozwadowski, Michelle
Braun, Thomas M.
Carlozzi, Noelle E.
Hassett, Afton L.
Johnson, Amanda K.
Shereck, Evan
Hanauer, David A.
Choi, Sung Won
Funding for this research was provided by:
American Society of Hematology (ASH) Bridge Grant (1R01HL146354)
NIH/NHLBI (1K24HL156896)
Edith S Briskin/Shirley K Schlafer Research Professorship,
Taubman Medical Research Institute
Article History
Received: 19 December 2024
Accepted: 16 April 2025
First Online: 15 July 2025
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki, as revised in 2013. The study was approved by the University of Michigan Medical School Institutional Review Board (IRBMED HUM#00186436) and registered on ClinicalTrials.gov (NCT04094844; registered 09–16 - 2019). IRBMED-approved informed consent was taken from all the study participants. The U-M IRBMED served as the Single IRB (sIRB) for this multi-site RCT.
: Not applicable.
: The authors declare no competing interests.